Skip to main content
. 2020 Jun 19;8(2):321. doi: 10.3390/vaccines8020321

Table 1.

Primers used in this study.

Name * Sequence (5′–3′)
Mouse CD8 Forward (mCD8a_F) CAGAGACCAGAAGATTGTCG
Mouse CD8 Reverse (mCD8a_R) TGATCAAGGACAGCAGAAGG
Mouse PD-1 Forward (mPD-1_F) CACAGTGTCAGAGGGAGCAA
Mouse PD-1 Reverse (mPD-1_R) TTGGGCAGCTGTATGATCTG
Mouse PD-L1 Forward (mPD-L1-F) CGAATCACGCTGAAAGTCAA
Mouse PD-L1 Reverse (mPD-L1-R) GCTGGTCACATTGAGAAGCA
Mouse CD86 Forward (mCD86-F) GCCCATTTACAAAGGCTCAA
Mouse CD86 Reverse (mCD86-R) TGTTCCTGTCAAAGCTCGTG
Mouse iNOS Forward (miNOS-F) CTCACTGGGACAGCACAGAA
Mouse iNOS Reverse (miNOS-R) GGTCAAACTCTTGGGGTTCA
Mouse Arg1 Forward (mArg1-F) CGCCTTTCTCAAAAGGACAG
Mouse Arg1 Reverse (mArg1-R) ACAGACCGTGGGTTCTTCAC
Mouse IL-10 Forward (mIL-10-F) GCCTTATCGGAAATGATCCA
Mouse IL-10 Reverse (mIL-10-R) TTTTCACAGGGGAGAAATCG
Mouse β-Actin Forward (BAT-Fw) GTCCCTCACCCTCCCAAAAG
Mouse β-Actin Reverse (BAT-Re) GCTGCCTCAACACCTCAACCC

Note: * CD8, cluster of differentiation 8; PD-1, programmed cell death-1; PD-L1, programmed cell death -ligand 1; CD86, cluster of differentiation 86; iNOS, inducible nitric oxide synthase; Arg1, arginase 1; IL-10, interleukin 10.